BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sirmai L, Pelletier AL, Gault N, Zallot C, Bouguen G, Bouchard D, Roland Nicaise P, Peyneau M, Sironneau S, Bittencourt MDC, Petitcollin A, Fernandez P, Roblin X, Siproudhis L, Abramowitz L. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study. World J Gastroenterol 2022; 28(9): 961-972 [PMID: 35317057 DOI: 10.3748/wjg.v28.i9.961]
URL: https://www.wjgnet.com/1007-9327/full/v28/i9/961.htm
Number Citing Articles
1
Marta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, Ignacio Omella Usieto, Ismael el Hajra Martinez, Elena Santos Pérez, Belén Menchén Viso, Virginia Matallana Royo, Irene González Partida, Rocío de Lucas Tellez de Meneses, Pablo Bella Castillo, Macarena González Rodriguez, María Isabel Vera Mendoza. Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeCrohn's & Colitis 360 2023; 5(1) doi: 10.1093/crocol/otac051
2
Alyssa M. Parian, Megan Obi, Phillip Fleshner, David A. Schwartz. Management of Perianal Crohn's DiseaseAmerican Journal of Gastroenterology 2023; 118(8): 1323 doi: 10.14309/ajg.0000000000002326
3
Kailei Ding, Jiayuan Kong, Ling Li, Florin M. Selaru, Alyssa Parian, Hai-Quan Mao. Advances in Pharmacology 2024;  doi: 10.1016/bs.apha.2024.10.013
4
Luke N. Hanna, Sulak Anandabaskaran, Nusrat Iqbal, Jeroen Geldof, Jean-Frédéric LeBlanc, Anders Dige, Lilli Lundby, Séverine Vermeire, André D’Hoore, Bram Verstockt, Gabriele Bislenghi, Danny De Looze, Triana Lobaton, Dirk Van de Putte, Antonino Spinelli, Michele Carvello, Silvio Danese, Christianne J. Buskens, Krisztina Gecse, Roel Hompes, Marte Becker, Jarmila van der Bilt, Wilhelmus Bemelman, Shaji Sebastian, Gordan Moran, Amy L. Lightner, Serre-Yu Wong, Jean-Frédéric Colombel, Benjamin L. Cohen, Stefan Holubar, Nik S. Ding, Cori Behrenbruch, Kapil Sahnan, Ravi Misra, Phillip Lung, Ailsa Hart, Phil Tozer. Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareClinical Gastroenterology and Hepatology 2024;  doi: 10.1016/j.cgh.2024.06.047
5
Tatiana Pacheco, Sara Monteiro, Luísa Barros, Jorge Silva. Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancerWorld Journal of Gastroenterology 2024; 30(28): 3373-3385 doi: 10.3748/wjg.v30.i28.3373
6
Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein. The use of core descriptors from the ENiGMA code study in recent literature: a systematic reviewColorectal Disease 2024; 26(3): 428 doi: 10.1111/codi.16893
7
Konstantinos Papamichael, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S. Cheifetz, Dorsaf Zoghlami, Sivan Harnik, Lieven Mulders, Nikolaos Kamperidis, Sylvia Sidky, Alexandra Bruss, Tina Deyhim, Mark A. Samaan, Andres J. Yarur, Byron P. Vaughn, Naila Arebi, Krisztina B. Gecse, Bella Ungar, Xavier Roblin, Stephane Paul, Robert Battat, Waqqas Afif, Laurent Peyrin-Biroulet, Peter M. Irving. Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s DiseaseClinical Gastroenterology and Hepatology 2024; 22(10): 2134 doi: 10.1016/j.cgh.2024.04.005